Papillary thyroid microcarcinoma: A study of 900 cases observed in a 60-year period

被引:450
作者
Hay, Ian D.
Hutchinson, Maeve E.
Gonzalez-Losada, Tomas
McIver, Bryan
Reinalda, Megan E.
Grant, Clive S.
Thompson, Geoffrey B.
Sebo, Thomas J.
Goellner, John R.
机构
[1] Mayo Clin & Coll Med, Div Endocrinol & Internal Med, Rochester, MN USA
[2] Mayo Clin & Coll Med, Div Biostat, Rochester, MN USA
[3] Mayo Clin & Coll Med, Div Gastroenterol & Gen Surg, Rochester, MN USA
[4] Mayo Clin & Coll Med, Div Anat Pathol, Rochester, MN USA
关键词
D O I
10.1016/j.surg.2008.08.035
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. The study aims were to characterize patients with papillary thyroid microcarcinoma (PTM) and to describe post-surgical outcome. Methods. Nine hundred PTM patients had initial treatment at Mayo Clinic during 1945-2004. Mean follow-up was 17.2 years. Recurrence and mortality details were derived from a computerized database. Results. Median tumor size was 7 mm; 98% were intrathyroidal. 273 patients (30%) had neck nodal involvement; 3 (0.3%) had distant metastases at diagnosis. Seven-hundred and sixty-five (85%) underwent bilateral lobar resection (BLR; total-, near-total, or bilateral subtotal thyroidectomy). Regional nodes were removed by either "node picking" (27%) or compartmental dissection (23%). Tumor resection was incomplete in 5 (0.6%). Radioiodine remnant ablation (RRA) was performed in 155 (17%). Overall survival did not differ from expected for an age and gender matched control group (P = .96); 3 patients (0.3%) died of PTM. None of the 892 patients with initial complete tumor resection developed metastatic spread during 20 postoperative years. Twenty-year and 40-year tumor recurrence rates were 6% and 8%, respectively. Higher recurrence rates were seen with multifocal tumors (P = .004) and node-positive patients (P <. 001). Neither more extensive surgery nor RRA reduced recurrence rates compared to unilateral lobectomy. Conclusion. More than 99%. of PTM patients are not at risk of distant spread or cancer mortality. RRA after BLR did not improve postoperative outcome. (Surgery 2008,144:980-8.)
引用
收藏
页码:980 / 987
页数:8
相关论文
共 27 条
[1]   Microcarcinoma of the thyroid [J].
Baloch, ZW ;
LiVolsi, VA .
ADVANCES IN ANATOMIC PATHOLOGY, 2006, 13 (02) :69-75
[2]  
Baudin E, 1998, CANCER, V83, P553, DOI 10.1002/(SICI)1097-0142(19980801)83:3<553::AID-CNCR25>3.0.CO
[3]  
2-U
[4]   Aggressiveness and outcome of papillary thyroid carcinoma (PTC) versus microcarcinoma (PMC): A mono-institutional experience [J].
Cappelli, C. ;
Castellano, M. ;
Braga, M. ;
Gandossi, E. ;
Pirola, I. ;
De Martino, E. ;
Agosti, B. ;
Rosei, E. Agabiti .
JOURNAL OF SURGICAL ONCOLOGY, 2007, 95 (07) :555-560
[5]   Papillary microcarcinoma of the thyroid - Prognostic significance of lymph node metastasis and multifocality [J].
Chow, SM ;
Law, SCK ;
Chan, JKC ;
Au, SK ;
Yau, S ;
Lau, WH .
CANCER, 2003, 98 (01) :31-40
[6]  
COX DR, 1972, J R STAT SOC B, V34, P187
[7]   Thyroid nodules: Is it time to turn off the US machines? [J].
Cronan, John J. .
RADIOLOGY, 2008, 247 (03) :602-604
[8]   Increasing incidence of thyroid cancer in the United States, 1973-2002 [J].
Davies, L ;
Welch, HG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (18) :2164-2167
[9]   Comparing USA and UK guidelines for the management of differentiated thyroid carcinoma [J].
Franklyn, JA .
THYROID, 2006, 16 (02) :105-107
[10]  
Hay Ian D, 2002, Trans Am Clin Climatol Assoc, V113, P241